SCHEMBL3760397

SCHEMBL3760397

O=[C]C(=O)c1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9936404 0.83 KMT2A (0.45)
SCHEMBL261605 0.81
SCHEMBL8844292 0.81
SCHEMBL263485 0.78 NPC1 (0.46)
SCHEMBL5829402 0.77 NPC1 (0.48)
SCHEMBL7583994 0.77 NPC1 (0.53)
SCHEMBL262313 0.77
SCHEMBL1324 0.77 NPC1 (0.62)
SCHEMBL2004766 0.77 NPC1 (0.52)
SCHEMBL1491811 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7186522-B2 Using detergents to reduce artifacts during staining of biological samples; medical diagnostics and cervical cancer CYTYC CORPORATION (US) 2007-03-06 US claimed
US-5051417-A Indolythiadiazines for treating heart failure LES LABORATOIRES BEECHAM S.A. (FR) 1991-09-24 US claimed
WO-2023179647-A1 THERAPEUTIC VESICLES AND METHODS OF PROCESSING THE SAME BEIJING THERAXYTE BIOSCIENCE CO., LTD. (CN) 2023-09-28 WO disclosed
WO-2023178500-A1 THERAPEUTIC VESICLES AND METHODS OF PROCESSING THE SAME BEIJING THERAXYTE BIOSCIENCE CO. LTD. (CN) 2023-09-28 WO disclosed
CN-115536556-A Process for producing alkylamine derivative and intermediate for producing the same 味之素株式会社 2022-12-30 CN disclosed
EP-3283057-A1 COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES Rochal Industries, LLC (US) 2018-02-21 EP disclosed
CN-107421796-A Solution for the tissue processing of biological sample 罗氏血液诊断股份有限公司 2017-12-01 CN disclosed
CN-103874913-B Solution for tissue processing of biological samples 罗氏血液诊断股份有限公司 2017-04-26 CN disclosed
EP-3142599-A1 BIOMIMETIC GRAFT OR IMPLANT AND METHODS FOR PRODUCING AND USING THE SAME The Board of Trustees of the University of Illinois (US) 2017-03-22 EP disclosed
WO-2016168196-A1 COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES ROCHAL INDUSTRIES, LLC (US) 2016-10-20 WO disclosed
WO-2015175596-A1 BIOMIMETIC GRAFT OR IMPLANT AND METHODS FOR PRODUCING AND USING THE SAME THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2015-11-19 WO disclosed
EP-0512844-B1 Targeted delivery of bone growth factors CELTRIX PHARMA (US) 1997-08-06 EP disclosed
US-5204330-A ANTIFUNGAL COMPOUNDS BEECHAM GROUP P.L.C. (GB) 1993-04-20 US disclosed
WO-1992020371-A1 TARGETED DELIVERY OF BONE GROWTH FACTORS CELTRIX PHARMACEUTICALS, INC. (US) 1992-11-26 WO disclosed
EP-0512844-A1 Targeted delivery of bone growth factors CELTRIX PHARMACEUTICALS, INC. (US) 1992-11-11 EP disclosed
EP-0431870-A1 Amphotericin B derivatives Beecham Group p.l.c. (GB) 1991-06-12 EP disclosed
US-4957905-A ANTIBIOTICS BEECHAM GROUP P.L.C. (GB) 1990-09-18 US disclosed
US-4921839-A Erythromycin a 11,12-carbonate 9-oxime derivatives BEECHAM GROUP P.L.C. (GB) 1990-05-01 US disclosed
EP-0307176-A2 Erythromycin derivatives BEECHAM GROUP PLC (GB) 1989-03-15 EP disclosed
EP-0284203-A2 Erythromycin derivatives, process for their preparation and their pharmaceutical use BEECHAM GROUP PLC (GB) 1988-09-28 EP disclosed